Monografie
Genetics of osteopontin in patients with chronic kidney disease: the German chronic kidney disease study
- Sprache
-
Englisch
- Identifier
-
1256033316
Beteiligte Personen und Organisationen
Cheng, Yurong
Li, Yong
Scherer, Nora
Grundner-Culemann, Franziska
Lehtimäki, Terho
Mishra, Binisha H.
Raitakari, Olli
Nauck, Matthias
Eckardt, Kai-Uwe
Sekula, Peggy
Schultheiß, Ulla Teresa
Walz, Gerd
Köttgen, Anna
Kotsis, Fruzsina
Meder, Simone
Mitsch, Erna
Reinhard, Ursula
GCKD investigators, [Study group]
Li, Yong
Scherer, Nora
Grundner-Culemann, Franziska
Lehtimäki, Terho
Mishra, Binisha H.
Raitakari, Olli
Nauck, Matthias
Eckardt, Kai-Uwe
Sekula, Peggy
Schultheiß, Ulla Teresa
Walz, Gerd
Köttgen, Anna
Kotsis, Fruzsina
Meder, Simone
Mitsch, Erna
Reinhard, Ursula
GCKD investigators, [Study group]
- DOI
-
10.1371/journal.pgen.1010139
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
03.06.2022, 09:17 MESZ
Objekttyp
- Monografie
Beteiligte
- Cheng, Yurong
- Li, Yong
- Scherer, Nora
- Grundner-Culemann, Franziska
- Lehtimäki, Terho
- Mishra, Binisha H.
- Raitakari, Olli
- Nauck, Matthias
- Eckardt, Kai-Uwe
- Sekula, Peggy
- Schultheiß, Ulla Teresa
- Walz, Gerd
- Köttgen, Anna
- Kotsis, Fruzsina
- Meder, Simone
- Mitsch, Erna
- Reinhard, Ursula
- GCKD investigators, [Study group]
Ähnliche Objekte (12)
Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study
Thyroid function, renal events and mortality in chronic kidney disease patients: the German Chronic Kidney Disease study
Apolipoprotein A‐IV concentrations and clinical outcomes in a large chronic kidney disease cohort: results from the GCKD study
Copeptin, natriuretic peptides, and cardiovascular outcomes in patients with CKD: the German Chronic Kidney Disease (GCKD) study
A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease
Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease
Results from the German Chronic Kidney Disease (GCKD) study support association of relative telomere length with mortality in a large cohort of patients with moderate chronic kidney disease
KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study
Prospective cohort study of soluble urokinase plasminogen activation receptor and cardiovascular events in patients with CKD
Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort
Differential prognostic utility of adiposity measures in chronic kidney disease
Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study
Thyroid function, renal events and mortality in chronic kidney disease patients: the German Chronic Kidney Disease study
Apolipoprotein A‐IV concentrations and clinical outcomes in a large chronic kidney disease cohort: results from the GCKD study
Copeptin, natriuretic peptides, and cardiovascular outcomes in patients with CKD: the German Chronic Kidney Disease (GCKD) study
A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease
Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease
Results from the German Chronic Kidney Disease (GCKD) study support association of relative telomere length with mortality in a large cohort of patients with moderate chronic kidney disease
KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study
Prospective cohort study of soluble urokinase plasminogen activation receptor and cardiovascular events in patients with CKD
Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort
Differential prognostic utility of adiposity measures in chronic kidney disease
Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study
Thyroid function, renal events and mortality in chronic kidney disease patients: the German Chronic Kidney Disease study
Apolipoprotein A‐IV concentrations and clinical outcomes in a large chronic kidney disease cohort: results from the GCKD study
Copeptin, natriuretic peptides, and cardiovascular outcomes in patients with CKD: the German Chronic Kidney Disease (GCKD) study
A polygenic score for reduced kidney function and adverse outcomes in a cohort with chronic kidney disease
Patterns of medication use and the burden of polypharmacy in patients with chronic kidney disease: the German Chronic Kidney Disease study
Frequent LPA KIV-2 variants lower lipoprotein(a) concentrations and protect against coronary artery disease
Results from the German Chronic Kidney Disease (GCKD) study support association of relative telomere length with mortality in a large cohort of patients with moderate chronic kidney disease
KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study
Prospective cohort study of soluble urokinase plasminogen activation receptor and cardiovascular events in patients with CKD
Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort